Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Cancer Science
|
March 13, 2024
Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma
Paula Duch, Natalia Díaz-Valdivia, Marta Gabasa, et al.
Anticancer Research
|
October 25, 2017
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab
Beatriz Wills, Andrés F Cardona, Leonardo Rojas, et al.
Clinical Lung Cancer
|
March 23, 2019
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns
Sergi Clavé, Natalia Rodon, Lara Pijuan, et al.
Carcinogenesis
|
October 10, 2015
Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts
Miguel Vizoso, Marta Puig, F Javier Carmona, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells
Miguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
July 5, 2022
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Paula Duch, Natalia Díaz-Valdivia, Rafael Ikemori, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Jordi Alcaraz, Josep Lluís Carrasco, Laura Millares, et al.
Cell Death & Disease
|
March 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer
Natalia Díaz-Valdivia, Paula Duch, Rafael Ikemori, et al.
Biomaterials Science
|
November 4, 2025
Silicon-based nanopillars: a novel platform for tissue applications
Cristiano Piergallini, Natalia Díaz-Valdivia, Alba Deyà, et al.
Targeted Oncology
|
June 17, 2017
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)
Andrés F Cardona, Oscar Arrieta, Martín Ignacio Zapata, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Cancer Science
|
March 13, 2024
Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma
Paula Duch, Natalia Díaz-Valdivia, Marta Gabasa, et al.
Anticancer Research
|
October 25, 2017
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab
Beatriz Wills, Andrés F Cardona, Leonardo Rojas, et al.
Clinical Lung Cancer
|
March 23, 2019
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns
Sergi Clavé, Natalia Rodon, Lara Pijuan, et al.
Carcinogenesis
|
October 10, 2015
Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts
Miguel Vizoso, Marta Puig, F Javier Carmona, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2008
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells
Miguel A Molina-Vila, Jordi Bertran-Alamillo, Noemí Reguart, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
July 5, 2022
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
Paula Duch, Natalia Díaz-Valdivia, Rafael Ikemori, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
Jordi Alcaraz, Josep Lluís Carrasco, Laura Millares, et al.
Cell Death & Disease
|
March 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer
Natalia Díaz-Valdivia, Paula Duch, Rafael Ikemori, et al.
Biomaterials Science
|
November 4, 2025
Silicon-based nanopillars: a novel platform for tissue applications
Cristiano Piergallini, Natalia Díaz-Valdivia, Alba Deyà, et al.
Targeted Oncology
|
June 17, 2017
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)
Andrés F Cardona, Oscar Arrieta, Martín Ignacio Zapata, et al.
Page
of 8